Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 NSCLC 2 Colorectal Neoplasms 2 Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 2a 1

Interventions

pembrolizumab 61 Carboplatin 44 Pemetrexed 31 Paclitaxel 31 Docetaxel 31 Cisplatin 27 Gemcitabine 24 Nivolumab 23 Erlotinib Hydrochloride 21 Bevacizumab 18 Ipilimumab 11 osimertinib 10 Drug Therapy 10 atezolizumab 9 Radiosurgery 9 Cyclophosphamide 9 Cetuximab 9 Blood Specimen Collection 9 durvalumab 8 cemiplimab 8 Radiotherapy 8 budigalimab 7 Fluorouracil 7 Dexamethasone 7 trametinib 6 fludarabine 6 dostarlimab 6 avelumab 6 Taxes 6 130-nm albumin-bound paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Liquid Biopsy × Thoracic × Clear all

NCT05254132 2022-02-24

SALMON

OncoRadiomics

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡